Substance P in the medial amygdala: Emotional stress-sensitive release and modulation of anxiety-related behavior in rats

Increasing evidence implicates the substance P (SP)/neurokinin-1 receptor system in anxiety and depression. However, it is not known whether emotional stimulation alters endogenous extracellular SP levels in brain areas important for processing of anxiety and mood, a prerequisite for a contribution of this neuropeptide system in modulating these behaviors. Therefore, we examined in rats whether the release of SP is sensitive to emotional stressors in distinct subregions of the amygdala, a key area in processing of emotions. By using in vivo micropush–pull superfusion and microdialysis techniques, we found a pronounced and long-lasting increase (150%) in SP release in the medial nucleus of the amygdala (MeA), but not in the central nucleus of the amygdala, in response to immobilization stress. SP release in the MeA was transiently enhanced (40%) in response to elevated platform exposure, which is regarded as a mild emotional stressor. Immobilization enhanced the anxiety-related behavior evaluated in the subsequently performed elevated plus-maze test. Bilateral microinjections of the neurokinin-1 receptor antagonist [2-cyclopropoxy-5-(5-(trifluoromethyl)tetrazol-1-yl)benzyl]-(2-phenylpiperidin-3-yl)amine into the MeA blocked the stress-induced anxiogenic-like effect, supporting a functional significance of enhanced SP release. In unstressed rats, the neurokinin-1 receptor antagonist displayed no significant anxiolytic effect but reversed the anxiogenic effect of SP microinjected into the MeA. Our findings identify the MeA as a critical brain area for the involvement of SP transmission in anxiety responses and as a putative site of action for the recently discovered therapeutic effects of SP antagonists in the treatment of stress-related disorders.

[1]  N. Ogawa,et al.  Effect of immobilization stress on neuropeptides and their receptors in rat central nervous system , 1986, Regulatory Peptides.

[2]  M. Adler,et al.  Substance P release in the rat periaqueductal gray and preoptic anterior hypothalamus after noxious cold stimulation: effect of selective mu and kappa opioid agonists. , 1997, The Journal of pharmacology and experimental therapeutics.

[3]  A. Fleming,et al.  The long lasting effects of electrical simulation of the medial preoptic area and medial amygdala on maternal behavior in female rats , 1999, Behavioural Brain Research.

[4]  M. Brandão,et al.  Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test , 1996, Physiology & Behavior.

[5]  J. Herman,et al.  Differential forebrain c-fos mRNA induction by ether inhalation and novelty: evidence for distinctive stress pathways , 1999, Brain Research.

[6]  L. Terenius,et al.  Elevation of substance P-like peptides in the CSF of psychiatric patients. , 1984, Biological psychiatry.

[7]  P. Kalivas,et al.  Substance P modulation of dopamine in the nucleus accumbens , 1984, Neuroscience Letters.

[8]  L. Swanson,et al.  Organization of projections from the basomedial nucleus of the amygdala: A PHAL study in the rat , 1996, The Journal of comparative neurology.

[9]  N. Canteras,et al.  The role of lateral septal NK1 receptors in mediating anxiogenic effects induced by intracerebroventricular injection of substance P , 2002, Behavioural Brain Research.

[10]  J. Lachowicz,et al.  The Gerbil Elevated Plus-maze II: Anxiolytic-like Effects of Selective Neurokinin NK1 Receptor Antagonists , 2002, Neuropsychopharmacology.

[11]  P. J. Larsen,et al.  Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stress. , 1995, Life sciences.

[12]  A. Bilkei-Gorzo,et al.  Diminished Anxiety- and Depression-Related Behaviors in Mice with Selective Deletion of the Tac1 Gene , 2002, The Journal of Neuroscience.

[13]  D. Smith,et al.  The substance P antagonist L-760,735 inhibits stress-induced NK1 receptor internalisation in the basolateral amygdala , 1999, Brain Research.

[14]  Guy Sandner,et al.  Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze , 1993, Behavioural Brain Research.

[15]  T. Kaneko,et al.  Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat , 1994, The Journal of comparative neurology.

[16]  B J Allen,et al.  Noxious Cutaneous Thermal Stimuli Induce a Graded Release of Endogenous Substance P in the Spinal Cord: Imaging Peptide ActionIn Vivo , 1997, The Journal of Neuroscience.

[17]  T. Unger,et al.  Central tachykinins: mediators of defence reaction and stress reactions. , 1995, Canadian journal of physiology and pharmacology.

[18]  P. Mantyh Neurobiology of substance P and the NK1 receptor. , 2002, The Journal of clinical psychiatry.

[19]  C. Dayas,et al.  Neuroendocrine responses to an emotional stressor: evidence for involvement of the medial but not the central amygdala , 1999, The European journal of neuroscience.

[20]  G. Chrousos,et al.  Neuroendocrinology of stress. , 2001, Endocrinology and metabolism clinics of North America.

[21]  R. Adamec,et al.  Effects of baseline anxiety on response to kindling of the right medial amygdala , 2000, Physiology & Behavior.

[22]  S. Hunt,et al.  Substance P receptors: Localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand , 1984, Brain Research.

[23]  B. McEwen,et al.  Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior , 2003, Nature Neuroscience.

[24]  Charles B. Nemeroff,et al.  Stress and psychiatric disorders , 1994 .

[25]  R. Roth,et al.  Mild footshock stress dissociates substance P from substance K and dynorphin from Met- and Leu-enkephalin , 1986, Brain Research.

[26]  G. Bernatzky,et al.  Characterization of substance P-like immunoreactivity in submammalian species by high performance liquid chromatography , 1985, Peptides.

[27]  P. Eneroth,et al.  Short-term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri-aqueductal grey and limbic regions of rat brain. , 1992, Acta physiologica Scandinavica.

[28]  R. Whelpton,et al.  Substance P modulation of striatal dopamine outflow is determined by M1 and M2 muscarinic receptors in male Wistar rats , 2000, Neuroscience Letters.

[29]  George B Stefano,et al.  The role of stress in neurodegenerative diseases and mental disorders. , 2002, Neuro endocrinology letters.

[30]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[31]  M Tanaka,et al.  Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. , 2000, European journal of pharmacology.

[32]  D. Blanchard,et al.  Innate and conditioned reactions to threat in rats with amygdaloid lesions. , 1972, Journal of comparative and physiological psychology.

[33]  D. Morilak,et al.  Modulatory effects of norepinephrine, acting on alpha1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress , 2002, Neuropharmacology.

[34]  J. Nurnberger,et al.  CSF substance P immunoreactivity in affective disorders , 1985, Biological Psychiatry.

[35]  U. Ungerstedt,et al.  Microdialysis combined with a sensitive radioimmunoassay. A technique for studying in vivo release of neuropeptides. , 1987, Journal of pharmacological methods.

[36]  S. File Anxiolytic Action of a Neurokinin1 Receptor Antagonist in the Social Interaction Test , 1997, Pharmacology Biochemistry and Behavior.

[37]  N. Singewald,et al.  Release of excitatory and inhibitory amino acids from the locus coeruleus of conscious rats by cardiovascular stimuli and various forms of acute stress , 1995, Brain Research.

[38]  N. Toschi,et al.  Brain oxytocin inhibits the (re)activity of the hypothalamo–pituitary–adrenal axis in male rats: involvement of hypothalamic and limbic brain regions , 2000, Regulatory Peptides.

[39]  R. Adamec Amygdala kindling and anxiety in the rat. , 1990, Neuroreport.

[40]  R G Hill,et al.  Distinct mechanism for antidepressant activity by blockade of central substance P receptors. , 1998, Science.

[41]  M. Davidson,et al.  Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. , 2002, The Journal of clinical psychiatry.

[42]  A. Siegel,et al.  Evidence that substance P is utilized in medial amygdaloid facilitation of defensive rage behavior in the cat , 1993, Brain Research.

[43]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[44]  A. Wheeldon,et al.  Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and mice , 2000, Neuropharmacology.

[45]  S. Paradiso The Emotional Brain: The Mysterious Underpinnings of Emotional Life , 1998 .

[46]  N. Canteras,et al.  Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus. , 1999, Neuroreport.

[47]  J. Calixto,et al.  Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. , 1996, European journal of pharmacology.

[48]  K. Kovács,et al.  Invited review c-Fos as a transcription factor: a stressful (re)view from a functional map , 1998, Neurochemistry International.

[49]  M. Massi,et al.  The psychopharmacology of tachykinin NK-3 receptors in laboratory animals , 2000, Peptides.

[50]  K. Yoshioka,et al.  Neurotransmitter functions of mammalian tachykinins. , 1993, Physiological reviews.

[51]  E. Brodin,et al.  Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions , 1994, Neuropeptides.

[52]  A. Armario,et al.  Recovery of the Hypothalamic-Pituitary-Adrenal Response to Stress , 2000, Neuroendocrinology.

[53]  S. Boyce,et al.  Intra-amygdala injection of the substance P (NK1 receptor) antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs , 2001, Neuropharmacology.

[54]  T. Crow,et al.  Distribution of neuropeptides in the limbic system of the rat: The amygdaloid complex , 1982, Neuroscience.

[55]  U. Ungerstedt,et al.  Potassium evoked in vivo release of substance P in rat caudate nucleus measured using a new technique of brain dialysis and an improved substance P-radioimmunoassay. , 1983, Acta physiologica Scandinavica. Supplementum.

[56]  P. Zwanzger,et al.  Substance P serum levels are increased in major depression: preliminary results , 2003, Biological Psychiatry.

[57]  T. Hökfelt,et al.  Neuroanatomical localisation of Substance P in the CNS and sensory neurons , 2000, Neuropeptides.

[58]  R. Adamec,et al.  The effect of kindling of different nuclei in the left and right amygdala on anxiety in the rat , 1994, Physiology & Behavior.

[59]  K. McCarson,et al.  Release of substance P into the superficial dorsal horn following nociceptive activation of the hindpaw of the rat , 1991, Brain Research.

[60]  W. Wuttke,et al.  Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamus. , 1987, Neuroendocrinology.

[61]  R. Landgraf Intracerebrally Released Vasopressin and Oxytocin: Measurement, Mechanisms and Behavioural Consequences , 1995, Journal of neuroendocrinology.

[62]  D. Ganten,et al.  Substance P Induces a Cardiovascular Defense Reaction in the Rat: Pharmacological Characterization , 1988, Circulation research.

[63]  T. Hökfelt,et al.  Distribution of substance P-like immunoreactivity in the central nervous system of the rat—I. Cell bodies and nerve terminals , 1978, Neuroscience.

[64]  T. Moroji,et al.  Effects of whole-body vibration stress on substance P- and neurotensin-like immunoreactivity in the rat brain. , 1990, Environmental research.

[65]  George R. Breese,et al.  Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety , 1996, Brain Research.

[66]  N. Singewald,et al.  Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment , 2002, Neuropharmacology.